Beyond recovery: the case for transforming UK clinical cancer research

Beyond recovery: the case for transforming UK clinical cancer research This position paper finds that Covid-19 has worsened pre-existing barriers to clinical cancer research and recovering to a pre-pandemic ‘normal’ for research won’t be enough to deliver world-class cancer outcomes. Instead, the UK government must choose to go beyond recovery by expanding clinical research capacity, transforming how research is delivered, and supporting innovative cancer research. Cancer Research UK